Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.60

€3.60

1.120%
-
1.120%
€30.00

€30.00

 
28.03.24 / Tradegate WKN: 520394 / Name: B.R.A.I.N. Biotechnology / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€20.00
26.03.24
-1.91%
€30.00
17.06.21
-64.36%
buy
Your prediction

B.R.A.I.N. Biotechnology Research and Information Network AG Stock

B.R.A.I.N. Biotechnology Research and Information Network AG gained 1.120% today.
The community is currently still undecided about B.R.A.I.N. Biotechnology Research and Information Network AG with 1 Buy predictions and 1 Sell predictions.
With a target price of 30 € there is potential for a 733.33% increase which would mean more than doubling the current price of 3.6 € for B.R.A.I.N. Biotechnology Research and Information Network AG.

Pros and Cons of B.R.A.I.N. Biotechnology Research and Information Network AG in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of B.R.A.I.N. Biotechnology Research and Information Network AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
B.R.A.I.N. Biotechnology Research and Information Network AG 1.120% -6.250% -10.000% -36.620% -1.099% -59.184% -60.656%
Formycon AG -0.960% -0.645% -4.644% -31.250% -17.204% -25.962% 52.224%
MagForce AG -20.000% 25.000% -33.333% -9.091% 150.000% -99.955% -99.961%
Biofrontera AG 0.300% -3.725% 5.660% -71.525% -17.445% -85.732% -94.085%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-11

Based on the provided financials, it's observed that B.R.A.I.N Biotechnology has an interesting financial perspective. As a company in a rather volatile industry, Biotechnology, the financials of the firm showcase a unique blend of stability and potential areas of growth. However, they also reveal certain risks and possible weaknesses.

Vorteile (Pros)

In terms of market capitalization, B.R.A.I.N Biotechnology seems to be making steady strides. With a market capitalization of approximately 88.7 million, the company appears to have a stable market presence. It's also noteworthy that the company has continuously secured revenue, as indicated by the revenue TTM (Trailing Twelve Months) of 54.698 million.

Comments

Prediction Sell
Perf. (%) -16.22%
Target price
Change
Ends at 21.03.23

Sell B.R.A.I.N. Biotechnology Research and Information Network AG
Show more

Buy B.R.A.I.N. Biotechnology Research and Information Network AG
Show more

Buy B.R.A.I.N. Biotechnology Research and Information Network AG
Show more

News

EQS-News: Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
EQS-News: Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
EQS-News: Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
EQS-News: Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials